1,101
Views
0
CrossRef citations to date
0
Altmetric
Acceptance & Hesitation

Perceptions of dengue risk and acceptability of a dengue vaccine in residents of Puerto Rico

ORCID Icon, , , , , , , , , , , , & show all
Article: 2323264 | Received 08 Nov 2023, Accepted 22 Feb 2024, Published online: 10 Apr 2024

References

  • Shepard DS, Undurraga EA, Halasa YA, Stanaway JD. The global economic burden of dengue: a systematic analysis. Lancet Infect Dis. 2016;16:935–20. doi:10.1016/S1473-3099(16)00146-8.
  • Centers for Disease Control and Prevention. About dengue: what you need to know; 2022. https://www.cdc.gov/dengue/about/index.html.
  • Halasa YA, Shepard DS, Zeng W. Economic cost of dengue in Puerto Rico. Am J Trop Med Hyg. 2012;86:745–52. doi:10.4269/ajtmh.2012.11-0784.
  • Sharp TM, Ryff KR, Alvarado L, Shieh WJ, Zaki SR, Margolis HS, Rivera-Garcia B. Surveillance for Chikungunya and dengue during the first year of Chikungunya virus circulation in Puerto Rico. J Infect Dis. 2016;214:475–81. doi:10.1093/infdis/jiw245.
  • Paz-Bailey G, Adams L, Wong JM, Poehling KA, Chen WH, McNally V, Atmar RL, Waterman SH. Dengue vaccine: recommendations of the advisory committee on immunization practices, United States, 2021. MMWR Recomm Rep. 2021;70:1–16. doi:10.15585/mmwr.rr7006a1.
  • Lim JK, Lee YS, Wilder-Smith A, Thiry G, Mahoney R, Yoon IK. Points for consideration for dengue vaccine introduction - recommendations by the dengue vaccine initiative. Expert Rev Vaccines. 2016;15:529–38. doi:10.1586/14760584.2016.1129279.
  • Wong JM, Adams LE, Durbin AP, Munoz-Jordan JL, Poehling KA, Sanchez-Gonzalez LM, Volkman HR, Paz-Bailey G. Dengue: a growing problem with new interventions. Pediatrics. 2022;149:149. doi:10.1542/peds.2021-055522.
  • Witteman HO, Chipenda Dansokho S, Exe N, Dupuis A, Provencher T, Zikmund-Fisher BJ. Risk communication, values clarification, and vaccination decisions. Risk Anal. 2015;35:1801–19. doi:10.1111/risa.12418.
  • Musa S, Kulo A, Bach Habersaat K, Skrijelj V, Smjecanin M, Jackson C. A qualitative interview study with parents to identify barriers and drivers to childhood vaccination and inform public health interventions. Hum Vaccin Immunother. 2021;17:3023–33. doi:10.1080/21645515.2021.1923346.
  • Dube E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J. Vaccine hesitancy: an overview. Hum Vaccin Immunother. 2013;9:1763–73. doi:10.4161/hv.24657.
  • Heininger U. An internet-based survey on parental attitudes towards immunization. Vaccine. 2006;24:6351–5. doi:10.1016/j.vaccine.2006.05.029.
  • Halpin C, Reid B. Attitudes and beliefs of healthcare workers about influenza vaccination. Nurs Older People. 2019;31:32–9. doi:10.7748/nop.2019.e1154.
  • Larson HJ, Gakidou E, Murray CJL. The vaccine-hesitant moment. N Engl J Med. 2022;387:58–65. doi:10.1056/NEJMra2106441.
  • Brewer NT, Chapman GB, Rothman AJ, Leask J, Kempe A. Increasing vaccination: putting psychological science into action. Psychol Sci Public Interest. 2017;18:149–207. doi:10.1177/1529100618760521.
  • Fernandez ME, Le YC, Fernandez-Espada N, Calo WA, Savas LS, Velez C, Aragon AP, Colón-López V. Knowledge, attitudes, and beliefs about human papillomavirus (HPV) vaccination among Puerto Rican mothers and daughters, 2010: a qualitative study. Prev Chronic Dis. 2014;11:E212. doi:10.5888/pcd11.140171.
  • Romaguera J, Caballero-Varona D, Tortolero-Luna G, Marrero E, Suarez E, Perez CM, Muñoz C, Palefsky J, Ortiz AP. Factors associated with HPV vaccine awareness in a population-based sample of Hispanic women in Puerto Rico. J Racial Ethn Health Disparities. 2016;3:281–90. doi:10.1007/s40615-015-0144-5.
  • Moreland A, Herlihy C, Tynan MA, Sunshine G, McCord RF, Hilton C, Poovey J, Werner AK, Jones CD, Fulmer EB, et al. Timing of state and territorial COVID-19 stay-at-home orders and changes in population movement — United States, March 1–May 31, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1198–203. doi:10.15585/mmwr.mm6935a2.
  • Strauss A, Corbin J. Basics of qualitative research: techniques and procedures for developing grounded theory. Thousand Oaks, CA: Sage Publications; 1998.
  • Quinn-Patton M. Qualitative research and evaluation methods. Thousand Oaks, CA: Sage Publications; 2015.
  • Parker C, Scott S, Geddes A. Snowball sampling. SAGE Research Methods Foundations; 2019. https://eprints.glos.ac.uk/6781/1/6781%20Parker%20and%20Scott%20(2019)%20Snowball%20Sampling_Peer%20reviewed%20pre-copy%20edited%20version.pdf.
  • Tomashek KM, Rivera A, Munoz-Jordan JL, Hunsperger E, Santiago L, Padro O, Garcia E, Sun W. Description of a large island-wide outbreak of dengue in Puerto Rico, 2007. Am J Trop Med Hyg. 2009;81:467–74. doi:10.4269/ajtmh.2009.81.467.
  • Gonzalez Feliciano L, Deseda C, Rivera A, Tomashek KM, Munoz-Jordan J, Hunsperger E, Padro O, Santiago LM, Soto E, Perez J, et al. Notes from the field: dengue epidemic — Puerto Rico, January–July 2010. MMWR Morb Mortal Wkly Rep. 2010;59:878. https://www.cdc.gov/mmWR/preview/mmwrhtml/mm5928a4.htm.
  • Tomashek KM, Rivera A, Torres-Velasquez B, Hunsperger EA, Munoz-Jordan JL, Sharp TM, Rivera I, Sanabria D, Blau DM, Galloway R, et al. Enhanced surveillance for fatal dengue-like acute Febrile illness in Puerto Rico, 2010-2012. PloS Negl Trop Dis. 2016;10(10):e0005025. doi:10.1371/journal.pntd.0005025.
  • Perez-Guerra CL, Rodriguez-Acosta RL, Soto-Gomez E, Zielinski-Gutierrez E, Pena-Orellana M, Santiago LM, Rivera R, Cruz RR, Ramírez V, Tomashek K, et al. Assessing the interest to participate in a dengue vaccine efficacy trial among residents of Puerto Rico. Hum Vaccin Immunother. 2012;8:905–15. doi:10.4161/hv.20056.
  • Elo S, Kyngas H. The qualitative content analysis process. J Adv Nurs. 2008;62:107–15. doi:10.1111/j.1365-2648.2007.04569.x.
  • Centers for Disease Control and Prevention. Dengue vaccine; 2024. https://www.cdc.gov/dengue/vaccine/index.html.
  • Centers for Disease Control and Prevention. Dengue - communication resources; 2024. https://www.cdc.gov/dengue/vaccine/parents/resources.html.
  • Yeganeh N, Curtis D, Kuo A. Factors influencing HPV vaccination status in a Latino population; and parental attitudes towards vaccine mandates. Vaccine. 2010;28:4186–91. doi:10.1016/j.vaccine.2010.04.010.
  • Hofman R, van Empelen P, Richardus JH, de Kok IM, de Koning HJ, van Ballegooijen M, Korfage IJ. Predictors of HPV vaccination uptake: a longitudinal study among parents. Health Educ Res. 2014;29:83–96. doi:10.1093/her/cyt092.
  • Kepka DL, Ulrich AK, Coronado GD. Low knowledge of the three-dose HPV vaccine series among mothers of rural Hispanic adolescents. J Health Care Poor Underserved. 2012;23:626–35. doi:10.1353/hpu.2012.0040.
  • Rodriguez DM, Major CG, Sanchez-Gonzalez L, Jones E, Delorey MJ, Alonso C, Rivera-Amill V, Paz-Bailey G, Adams LE. Dengue vaccine acceptability before and after the availability of COVID-19 vaccines in Puerto Rico. Vaccine. 2023;41(24):3627–35. doi:10.1016/j.vaccine.2023.04.081.
  • Bond L, Nolan T. Making sense of perceptions of risk of diseases and vaccinations: a qualitative study combining models of health beliefs, decision-making and risk perception. BMC Public Health. 2011;11:943. doi:10.1186/1471-2458-11-943.
  • Drazkowski D, Trepanowski R. Reactance and perceived disease severity as determinants of COVID-19 vaccination intention: an application of the theory of planned behavior. Psychol Health Med. 2022;27:2171–8. doi:10.1080/13548506.2021.2014060.
  • Zampetakis LA, Melas C. The health belief model predicts vaccination intentions against COVID-19: a survey experiment approach. Appl Psychol Health Well Being. 2021;13:469–84. doi:10.1111/aphw.12262.
  • Geoghegan S, O’Callaghan KP, Offit PA. Vaccine safety: myths and misinformation. Front Microbiol. 2020;11:372. doi:10.3389/fmicb.2020.00372.
  • Troiano G, Nardi A. Vaccine hesitancy in the era of COVID-19. Public Health. 2021;194:245–51. doi:10.1016/j.puhe.2021.02.025.
  • Jennings W, Stoker G, Bunting H, Valgarethsson VO, Gaskell J, Devine D, McKay L, Mills MC. Lack of trust, conspiracy beliefs, and social media use predict COVID-19 vaccine hesitancy. Vaccines (Basel). 2021;9. doi:10.3390/vaccines9060593.
  • Marks L. Human Guinea pigs? The history of the early oral contraceptive clinical trials. Hist Technol. 1999;15:263–88. doi:10.1080/07341519908581949.
  • Benin AL, Wisler-Scher DJ, Colson E, Shapiro ED, Holmboe ES. Qualitative analysis of mothers’ decision-making about vaccines for infants: the importance of trust. Pediatrics. 2006;117:1532–41. doi:10.1542/peds.2005-1728.
  • Centers for Disease Control and Prevention. Vaccinate with confidence: strategy to reinforce confidence in COVID-19 vaccines; 2021. https://www.cdc.gov/vaccines/covid-19/vaccinate-with-confidence/strategy.html.
  • Dayrit MM, Mendoza RU, Valenzuela SA. The importance of effective risk communication and transparency: lessons from the dengue vaccine controversy in the Philippines. J Public Health Policy. 2020;41:252–67. doi:10.1057/s41271-020-00232-3.
  • Henrich N, Holmes B. The public’s acceptance of novel vaccines during a pandemic: a focus group study and its application to influenza H1N1. Emerg Health Threats J. 2009;2:e8. doi:10.3134/ehtj.09.008.
  • Colon-Lopez V, Quinones V, Del Toro-Mejias LM, Conde-Toro A, Serra-Rivera MJ, Martinez TM, Rodríguez V, Berdiel L, Villanueva H. HPV awareness and vaccine willingness among Dominican immigrant parents attending a federal qualified health clinic in Puerto Rico. J Immigr Minor Health. 2015;17:1086–90. doi:10.1007/s10903-014-0067-y.
  • Melin K, Zhang C, Zapata JP, Rivera YM, Fernandez K, Shacham E, Malavé-Rivera SM, Rodriguez-Diaz CE. Factors associated with intention to receive vaccination against COVID-19 in Puerto Rico: an online survey of adults. Int J Environ Res Public Health. 2021;18:7743. doi:10.3390/ijerph18157743.
  • Moucheraud C, Guo H, Macinko J. Trust in governments and health workers low globally, influencing attitudes toward health information, vaccines. Health Aff. 2021;40:1215–24. doi:10.1377/hlthaff.2020.02006.
  • Halstead SB, Katzelnick LC, Russell PK, Markoff L, Aguiar M, Dans LR, Dans AL. Ethics of a partially effective dengue vaccine: lessons from the Philippines. Vaccine. 2020;38:5572–6. doi:10.1016/j.vaccine.2020.06.079.
  • Hunsperger E, Peeling R, Gubler D, Eong Ooi E. Dengue pre-vaccination serology screening for the use of Dengvaxia®. Editorial J Travel Med. 2019;26. doi:10.1093/jtm/taz092.
  • Wilder-Smith PGS, Luo R, Kelly-Cirino C, Curry D, Larson H, Durbin A, Chu M, Tharmaphornpilas P, Ng LC, Sartori AMC, et al. Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: a meeting report. Vaccine. 2019;37:5137–46. doi:10.1016/j.vaccine.2019.07.016.
  • Departamento de Salud de Puerto Rico. Política Pública sobre el Uso de Vacunas para Prevenir el Dengue; 2022. https://www.vacunatepr.com/_files/ugd/be29f3_a4402039376f47688e3538910d8abd42.pdf.
  • Giles EL, Robalino S, McColl E, Sniehotta FF, Adams J. The effectiveness of financial incentives for health behaviour change: systematic review and meta-analysis. PLoS One. 2014;9:e90347. doi:10.1371/journal.pone.0090347.
  • Hadinegoro SR, Arredondo-Garcia JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, Hj Muhammad Ismail HI, Reynales H, Limkittikul K, Rivera-Medina DM, et al. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N Engl J Med. 2015;373(13):1195–206. doi:10.1056/NEJMoa1506223.
  • Sridhar S, Luedtke A, Langevin E, Zhu M, Bonaparte M, Machabert T, Savarino S, Zambrano B, Moureau A, Khromava A, et al. Effect of dengue Serostatus on dengue vaccine safety and efficacy. N Engl J Med. 2018;379(4):327–40. doi:10.1056/NEJMoa1800820.